Literature DB >> 34410821

GDP in Dialysis Associates With Peritoneal Vascular Remodeling in Kidney Disease.

Qimei Han1, Zyare J Orr1,2, Godfrey K Desouza1,3, Zsolt Bagi4, R Daniel Rudic1.   

Abstract

Entities:  

Keywords:  Editorials; glucose; inflammation; omentum; peritoneum; vascular remodeling

Mesh：

Year:  2021        PMID： 34410821      PMCID： PMC8384120          DOI： 10.1161/CIRCRESAHA.121.319785

Source DB:  PubMed          Journal:  Circ Res        ISSN： 0009-7330            Impact factor:   23.213


× No keyword cloud information.
  11 in total

1.  Global trends in rates of peritoneal dialysis.

Authors:  Arsh K Jain; Peter Blake; Peter Cordy; Amit X Garg
Journal:  J Am Soc Nephrol       Date:  2012-02-02       Impact factor: 10.121

2.  Damage to the peritoneal membrane by glucose degradation products is mediated by the receptor for advanced glycation end-products.

Authors:  Vedat Schwenger; Christian Morath; Alexander Salava; Kerstin Amann; Yuri Seregin; Reinhold Deppisch; Eberhard Ritz; Angelika Bierhaus; Peter P Nawroth; Martin Zeier
Journal:  J Am Soc Nephrol       Date:  2005-11-30       Impact factor: 10.121

3.  Long-term clinical effects of a peritoneal dialysis fluid with less glucose degradation products.

Authors:  B Rippe; O Simonsen; O Heimbürger; A Christensson; B Haraldsson; G Stelin; L Weiss; F D Nielsen; S Bro; M Friedberg; A Wieslander
Journal:  Kidney Int       Date:  2001-01       Impact factor: 10.612

4.  Advanced glycation end products in children with chronic renal failure and type 1 diabetes.

Authors:  Joachim Misselwitz; Sybille Franke; Eberhard Kauf; Ulrike John; Günter Stein
Journal:  Pediatr Nephrol       Date:  2002-05       Impact factor: 3.714

5.  The initial steps of ovarian cancer cell metastasis are mediated by MMP-2 cleavage of vitronectin and fibronectin.

Authors:  Hilary A Kenny; Swayamjot Kaur; Lisa M Coussens; Ernst Lengyel
Journal:  J Clin Invest       Date:  2008-04       Impact factor: 14.808

6.  The Euro-Balance Trial: the effect of a new biocompatible peritoneal dialysis fluid (balance) on the peritoneal membrane.

Authors:  John D Williams; Nicholas Topley; Kathrine J Craig; Ruth K Mackenzie; Monika Pischetsrieder; Cristina Lage; Jutta Passlick-Deetjen
Journal:  Kidney Int       Date:  2004-07       Impact factor: 10.612

7.  Trends in Peritoneal Dialysis Use in the United States after Medicare Payment Reform.

Authors:  Caroline E Sloan; Cynthia J Coffman; Linda L Sanders; Matthew L Maciejewski; Shoou-Yih D Lee; Richard A Hirth; Virginia Wang
Journal:  Clin J Am Soc Nephrol       Date:  2019-11-21       Impact factor: 8.237

8.  Reduced systemic advanced glycation end products in children receiving peritoneal dialysis with low glucose degradation product content.

Authors:  Claus Peter Schmitt; Dorothee von Heyl; Susanne Rieger; Klaus Arbeiter; Klaus Eugen Bonzel; Michel Fischbach; Joachim Misselwitz; Ann-Kathrin Pieper; Franz Schaefer
Journal:  Nephrol Dial Transplant       Date:  2007-04-09       Impact factor: 5.992

9.  Cell barrier function of resident peritoneal macrophages in post-operative adhesions.

Authors:  Tomoya Ito; Yusuke Shintani; Laura Fields; Manabu Shiraishi; Mihai-Nicolae Podaru; Satoshi Kainuma; Kizuku Yamashita; Kazuya Kobayashi; Mauro Perretti; Fiona Lewis-McDougall; Ken Suzuki
Journal:  Nat Commun       Date:  2021-04-14       Impact factor: 14.919

10.  Glucose Derivative Induced Vasculopathy in Children on Chronic Peritoneal Dialysis.

Authors:  Maria Bartosova; Conghui Zhang; Betti Schaefer; Rebecca Herzog; David Ridinger; Ivan Damgov; Eszter Levai; Iva Marinovic; Christoph Eckert; Philipp Romero; Peter Sallay; Akos Ujszaszi; Markus Unterwurzacher; Anja Wagner; Georg Hildenbrand; Bradley A Warady; Franz Schaefer; Sotirios G Zarogiannis; Klaus Kratochwill; Claus Peter Schmitt
Journal:  Circ Res       Date:  2021-07-08       Impact factor: 17.367
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.